Federal Official Gazette
ANS PUBLIC CONSULTATION No. 163, OF OCTOBER 31, 2025. Art. 1° A Public Consultation is hereby opened, with a period of 20 (twenty) days, from November 5 to 24, 2025, for the submission of criticism and suggestions regarding the preliminary recommendation of non-incorporation for the technologies contained in UAT No. 171 – Inclisirana, UAT No. 175 – Lebriquizumabe and UAT No. 176 – Momelotinibe
ANS news
No updates.
Open public consultations
There are no open consultations.
Scheduled public hearings
There are no scheduled hearings.
Open public calls for input
There are no open public calls for input.
Open public calls
No updates.
Other news
Supplementary health has a regulatory gap for brokers
Source: cqcs.com.br · read the full article
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.